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The human gut microbiome has a considerable impact on host health. The long list
of microbiome-related health disorders raises the question of what in fact determines
microbiome composition. In this review we sought to understand how the host itself
impacts the structure of the gut microbiota population, specifically by correlations of
host genetics and gut microbiome composition. Host genetic profile has been linked
to differences in microbiome composition, thus suggesting that host genetics can
shape the gut microbiome of the host. However, cause-consequence mechanisms
behind these links are still unclear. A survey of the possible mechanisms allowing host
genetics to shape microbiota composition in the gut demonstrated the major role of
metabolic functions and the immune system. A considerable impact of other factors,
such as diet, may outweigh the effects of host genetic background. More studies are
necessary for good understanding of the relations between the host genetic profile,
gut microbiome composition, and host health. According to the idea of personalized
medicine, patient-tailored management of microbiota content remains a fascinating area
for further inquiry.
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INTRODUCTION
The human gut houses a complex community of microbes whose number is estimated to be 10
times higher than the number of cells in the whole body. These microbial communities, called
the gut microbiome, are dynamic populations that differ from one person to another and that
change their structure with time. Gut microbiotas interact with their hosts in many ways; thus
composition of a microbiome may impact the balance of the whole system, and changes in
microbial communities may exert significant effects on an individual’s health. Thus, microbes can
be used in strategies addressing modulation of microbiome functionality, i.e., they can be used as
probiotics (Savage, 1977; Kau et al., 2011; Linares et al., 2016). An extensive review on probiotic
roles played by the microbiota has recently been published by Linares et al. (2016).
The importance of the gut microbiota for human health has been widely appreciated during this
and the previous decade. The least surprising was their effect on gastrointestinal tract functions
and diseases such as ulcerative colitis (Macfarlane et al., 2005; Sokol et al., 2006a,b; Linares et al.,
2016) gastroenteritis (Barman et al., 2008), and celiac disease (Nadal et al., 2007). Abnormalities
in composition of gut bacteria are considered as an important factor promoting inflammatory
bowel disease including Crohn’s disease (Kassinen et al., 2007; Dicksved et al., 2008; Collins
et al., 2009; Linares et al., 2016; Manuc et al., 2016). Since gut bacteria are involved in metabolic
transformations and energy harvest, they have been reported as a biotic factor regulating body
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weight, potentially linked to a risk of obesity and other metabolic
disorders (Backhed et al., 2004; Turnbaugh et al., 2006, 2009;
Cani and Delzenne, 2009; Ley, 2010). However, in this field also
controversies have been pointed out, like the complex character
of studied phenomenon, the necessity of studies based on
observation and description in opposition to studies performed
to confirm a hypothesis and the independence from the food
industry (Angelakis et al., 2012; Lagier et al., 2012).
Gut microbiota composition has been linked to functions
of organs and tissues far beyond the gut itself. Probably the
most spectacular is the so-called gut–brain axis; biochemical
signaling between the gastrointestinal tract and the nervous
system is important for healthy brain function. This relationship
involves the gut microbiome, the composition of which may
be linked to neuropsychiatric diseases (Mu et al., 2016; Yarandi
et al., 2016). Another important role of the natural microbiome
is liver homeostasis, since bacterial metabolites in dysbiosis
can be linked to the pathogenesis of liver disease (Haque and
Barritt, 2016). Microbial metabolites belonging to short-chain
fatty acids (butyrate) may affect the whole system of the host, even
mitigating graft-versus-host disease (GVHD), the most probably
by regulation of histone acetylation (Mathewson et al., 2016).
Some findings reveal that the microbiomes of the lung and
gut contribute to the pathogenesis of asthma and allergy by
regulation of helper T cell subsets that affect the development of
immune tolerance (Russell et al., 2012; Riiser, 2015).
The long list of microbiome-related health disorders raises
the question of what in fact decides on microbiome composition.
Ecological sciences define factors that shape microbial
community structure as a combination of environmental
factors such as diet, and host-defined ones. In fact, there is a high
interaction between the microbiome and the host, and for that
reason both of them have evolved together, which may explain
possible microbiome adaptations (Cavender-Bares et al., 2009;
Walter and Ley, 2011; Leamy et al., 2014; Linares et al., 2016).
Relating individual microbiome composition to host genetics
may constitute a link between probiotic studies and personalized
medicine. In this review we aim to bring together recent findings
that demonstrate the link between human host genetics and the
gut microbiota, from the perspective of practical implications of
this knowledge for humans’ health.
LINKS BETWEEN HOST GENETIC
PROFILE AND INDIVIDUAL GUT
MICROBIOME IN HUMANS
The question of how genotype and environmental exposure
influence the gut microbiome has been addressed in a twin
pairs study by Turnbaugh et al. (2009). Fecal microbiota
were characterized in 154 adult individuals comprising female
monozygotic or dizygotic twins and their mothers, if available.
In this group, the gut microbiota was similar among family
members, but individual variations were observed, i.e., specific
bacterial lineages were present in each person’s gut. These
variations were assessed in monozygotic and in dizygotic
twins, and the analysis showed a comparable degree of co-
variation between these groups. The authors found their
observation consistent with an earlier study of adult twins by
fingerprinting (Zoetandal et al., 2001). These findings contradict
the hypothesis of a substantial impact of host genetics on
microbiome composition and they are in line with observation
of Murphy et al. (2015) who studied dichorionic triplet sets.
In these group only at the 1st month of life monozygotic
pair shared microbiota distinct to the fraternal sibling. At
the 12th month no significant differences were observed.
However, some limitations of the studied have been pointed
out. First, small groups: 20–30 twin pairs in each category
in studies of Turnbaugh et al. (2009) and three triplet sets
in studies of Murphy et al. (2015). Second, broad measures
of the microbiome composition instead of individual bacterial
representation was investigated (Davenport et al., 2015; Murphy
et al., 2015).
Recent studies by Goodrich et al. (2014) analyzed microbiotas
in fecal samples obtained from the TwinsUK population
(416 twin pairs); microbiomes were found more similar for
monozygotic than dizygotic twins. The study also revealed
differences between bacterial families; the analyses of distance
metrics in the three most dominant bacterial families –
the Lachnospiraceae and Ruminococcaceae (Firmicutes)
and Bacteroidaceae – demonstrated greater similarities
between monozygotic twins within the Ruminococcaceae
and Lachnospiraceae than those between dizygotic twins.
Similar pair-wise diversity was restricted to the Bacteroidaceae
family, so this group was suggested to be more responsive
to environmental factors (Goodrich et al., 2014). Moreover,
datasets from Turnbaugh et al. (2009) and Yatsunenko et al.
(2012) were re-analyzed, validating the observation that the
representation of bacterial taxa in the gut is more similar
within monozygotic than dizygotic twin pairs (Goodrich et al.,
2014).
Davenport et al. (2015) applied a genome-wide association
study (GWAS) to investigate the fecal microbiome from a
religious isolated group, the Hutterites who live on communal
farms. The Hutterites are not an outbred population, but
rather a genetic isolate exhibiting a strong founder effect
(Coghlan and Zelinski, 2016). They are also an isolated
population due to the communal farming, therefore variations
of environmental factors have less impact on individuals’
microbiomes (Davenport et al., 2015; Igartua et al., 2016).
These features make this population a unique model for
genome and microbiome studies. The study in 127 participants
demonstrated that the abundances of at least eight bacterial
taxa were associated with host genome single nucleotide
polymorphisms (SNPs), including those previously associated
with BMI in obesity studies. The differentiation of bacterial
taxa abundances between male and female participants was
also reported, however, this element must be considered with
caution. Hutterite society practice substantially different daily
activities of men and women which could drive sex-specific
differences (Davenport et al., 2015; Davenport, 2016). In the
report within the Human Microbiome Project, most variation
in the human microbiome could not be well explained by their
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relation to gender (Human Microbiome Project Consortium,
2012a,b).
MURINE MODELS DEMONSTRATE THAT
HOST GENETIC PROFILE CAN SHAPE
GUT MICROBIOME
The relation between the composition of gut microbiota and the
host genetic profile has been clearly demonstrated in murine
models. Benson et al. (2010) showed that composition of the gut
microbiota behaves as a polygenic trait (i.e., resultative phenotype
cumulates effects of more than one gene), and they identified
in mice 18 host quantitative trait loci (QTL) that correlated
with relative abundances of particular microbial groups. This
correlation showed that heritable genetic factors may govern
intimate associations between the host and its microbiota,
although additional efforts will be needed to explain in details
which physiological mechanisms are involved. The study was
done in a large (n = 645) murine intercross model (G4) in which
the environmental factors were carefully controlled (Table 1).
The same study revealed that in the case of some taxonomic
groups of bacteria, e.g., lactobacilli, host genetic control
is probably exerted at the lower taxonomic ranks, i.e., at
the species level and below. No QTL were identified for
Lactobacillus (genus), so they mapped as individual traits the
relative abundance of three Lactobacillus groups with 97%
identity – Lactobacillus reuteri, L. johnsonii/L. gasseri, and
L. animalis/L. murinus – to test for co-segregation at the species
level. This analysis revealed that the L. johnsonii/L. gasseri group
segregated with two significant QTL on MMU14 and MMU7
(Benson et al., 2010). Interestingly, in the case of Helicobacter
(genus) significant QTL were detected. Both Helicobacter and
Lactobacillus interact directly and adhere to host tissues, so
both genera would be expected to have intrinsic susceptibility to
modulation by host factors (Benson et al., 2010).
As reported by Leamy et al. (2014), a study of G10 mouse
population (continued) revealed 42 microbiota-specific QTL in
27 different genomic regions that affected the relative abundances
of 39 (out of the 203, i.e., 19%) microbial taxa in the murine
gut. When using a strict approach the authors proposed 20
QTL as underlying genetic variation affecting the microbiota
composition. The lowest FDR (false discovery rate) values, which
means the greatest support, were for QTL on MMU9 affecting
Alistipes (Leamy et al., 2014), that have been so far reported as
over-represented in patients with depression (Jiang et al., 2015).
It is not clear what is the strength of these genome-related
effects on microbiomes. As previously mentioned, many other
factors (diet, life style, colonization order, etc.) contribute to
the resultant effect. The group of Turnbaugh reported that diet
dominated host genotype in shaping the gut microbiome. In
mice deficient for genes linked to host-microbial interactions
[MyD88(-/-), NOD2(-/-), ob/ob, and Rag1(-/-)] and in wild-
type mice, gut microbiota were similarly modified by the diet.
Further, the structural changes in the microbial community that
were observed after dietary changes were rapid, reproducible,
and reversible, thus implying the predominant role of the diet
in shaping the gut microbiome (Carmody et al., 2015). Other
studies dedicated to phylotypes associated with obesity, suggested
that host genetic factors influenced gut microbiota plasticity
in response to diet (Parks et al., 2013); this emphasizes the
multilateral dependencies between various factors engaged in
microbiome forming processes.
MECHANISMS THAT LINK HOST
GENETICS AND GUT MICROBIOTA
COMPOSITION
In spite of the growing volume of data explaining how the gut
microbiota affects host physiology and health, explanations of
how host genetics shapes the structure of the gut microbiome
are very scarce. In general, the authors propose immune
functions, metabolism, energy regulation, gut motility, and
adhesion interactions as the most expected genetics-dependent
physiological phenomena that may impact the gut microbiota
TABLE 1 | Correlations of body traits and microbiome traits by the same quantitative trait loci.
Correlation by QTLs Reference
Body trait Microbiome trait
Fat content OTU3615 (Actinobacteria) Leamy et al., 2014
Fat content OTU22207 (Alistepes) Leamy et al., 2014
Weight and fat content OTU30840 (Clostridium) Leamy et al., 2014
Weight Lactococcus lactis Leamy et al., 2014
Immune response Coriobacteriaceae Benson et al., 2010
Immune response Lactococcus Benson et al., 2010
Susceptibility to colon tumors Coriobacteriaceae Benson et al., 2010
Susceptibility to hepatocellular carcinomas Turicibacter Benson et al., 2010
Region syntenic with this associated with Crohn’s disease in humans Barnesiella Benson et al., 2010
Weight Akkermansia Davenport et al., 2015
Olfactory receptor (response to bacterial metabolites) Bifidobacterium Davenport et al., 2015
Olfactory receptor (response to bacterial metabolites) Faecalibacterium Davenport et al., 2015
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(Benson et al., 2010; Leamy et al., 2014; Davenport et al., 2015).
A survey of the possible mechanisms allowing host genetics to
shape microbiota composition in the gut demonstrated the major
role of metabolic functions and the immune system (Table 1).
Benson et al. (2010) pointed out that QTL for
Coriobacteriaceae and Lactococcus (located on MMU10)
identified in their study were closely positioned with several
genes engaged in immune responses and regulation. These
comprised the TLR2 pathway, IFN-gamma, and IL-22, important
in the immune response in mucosal surfaces. The authors
also discussed a microbiome-related QTL on MMU1 that
overlaps the conserved gene ATG16L, and the region is syntenic
with a region of human chromosome 2 already shown to be
associated with Crohn’s disease (Parkes et al., 2007; Benson
et al., 2010). The pathogenesis of Crohn’s disease has been
so far recognized as a result of the gut microbiome and
environmental factors leading to an abnormal immune response
in a genetically predisposed patient. Possible factors promoting
and mitigating Crohn’s disease have been recently discussed
in an extensive review by Manuc et al. (2016). Interestingly,
some Crohn’s associated gene polymorphisms have been
demonstrated as affecting both the immune response and the
microbiota. For instance, the innate immune response is affected
by the polymorphism of nucleotide-binding oligomerization
domain-containing protein 2 (NOD2)/caspase recruitment
domain-containing protein 15 (CARD15); NOD2 acts through
the NF-kB pathway, which is also responsive to bacterial wall
components (muramyl dipeptide). An inadequate antibacterial
response related to NOD2 has been linked to probably
lower production of alpha defensins (antimicrobial peptides)
by Paneth cells or by an incorrect autophagy cascade with
increased levels of NF-kB. It is associated with the highest risk
of ileal involvement, stenoses or fistulas in Crohn’s disease
(Adler et al., 2011; Lee and Lee, 2014; Strober et al., 2014;
Manuc et al., 2016). Genetic variants that may also lead to
an increased risk of Crohn’s disease are linked to Toll-like
receptor 4 (TLR-4), typically responsible for recognizing bacterial
lipopolysaccharide, CARD9 (caspase recruitment domain-
containing protein 9), engaged in defense against pathogens
such as yeasts, and interleukin 23 receptor (IL-23R), while
IL-23 has been implicated in inhibiting the development
of regulatory T cell development in the intestine (Liu and
Anderson, 2014; Manuc et al., 2016). Khachatryan et al. (2008)
demonstrated significant changes in microbiome structure in
patients with an autoinflammatory disorder called familial
Mediterranean fever (related to mutations in the MEFV gene).
Their microbiome was substantially disturbed even during
remissions.
The relations between gut bacteria and the central nervous
system (the brain-gut axis) also engage immune system and
endocrine elements. Stress has been demonstrated in rodents
as the altering factor for gut microbiota through immune-
activation, probably due to changes in bacterial translocation
and resulting increase in stimulation of the innate immune
system (O’Mahony et al., 2009; Bailey et al., 2011). As pointed
out by Cryan and Dinan (2012) the mechanisms underlying
this relation engage autonomic nervous system (ANS) and
hypothalamus-pituitary-adrenal (HPA) axis that can modulate
gut motility, secretion and epithelial permeability which impacts
the niche environment for microbiota. CNS may induce signals
for neurons, immune cells and others secretory cells in the
gut that release a variety of signaling molecules as well as
anti-microbial peptides (AMPs) and modify composition of gut
microbiota (Rhee et al., 2009; Cryan and Dinan, 2012; Wang and
Kasper, 2014).
Some of the identified microbiome-related QTL (on
MMU7 and MMU10, for Turicibacter and Coriobacteriaceae,
respectively) overlapped with QTL for murine susceptibility to
carcinomas and tumor development (Benson et al., 2010). In
these cases the possible role of immunological functions has not
been explained yet, although tumor development usually involves
complex immunological processes.
Other observations suggest that gene-encoded metabolic
characteristics influence microbiome structure. For example,
an correlation has been identified between a bacterial taxon
associated with obesity (genus Akkermansia) and a variant near
PLD1, a gene related to body mass index (Everard et al., 2013;
Davenport et al., 2015). Evolutionary studies of vertebrates and
typical composition of their gut microflora suggest that the
microbiome is shaped by stomach acidity; this was confirmed
by the analysis of microbiome modifications correlating with
evolutionary changes of animals (Beasley et al., 2015).
Gene set enrichment analysis (GSEA) performed by
Davenport et al. (2015) revealed the olfactory receptor activity
significant for five taxons (family Succinivibrionaceae, genus
Bifidobacterium, order Rhizobiales, genus Anaerofilum, genus
Faecalibacterium). It had been previously demonstrated in
mice that in the kidneys an olfactory receptor responded to
metabolites produced by gut bacteria; this process affects renin
production and it results in systemic modifications of blood
pressure (Pluznick et al., 2013). Davenport et al. (2015) proposed
that olfactory receptors that may be expressed in other tissues
can also recognize compounds secreted by the microbiota. These
olfactory receptors could play a role in host-driven regulation
either for host physiology or for the microbiota in response to the
gut environment.
DISCUSSION
In this review we present reports that suggest that the host genetic
profile may shape the gut microbiome of the host. Some studies
were contradictory to this statement, such as the first twin pairs
analyses (Turnbaugh et al., 2009), but others revealed a possible
relation between host genetics and the microbiota in the gut.
A very interesting hypothesis was presented by Murphy et al.
(2015) basing on results in a group of dichorionic triplet set that
contained a pair of monozygotic twins and a fraternal sibling.
Host genetics seems to play a role in the composition of an
individual’s gut microbiome at the initial stage of life (1 month),
but later (12 months) environmental factors become a major
determinant.
It should be emphasized that the volume of relevant data is
still small, which results mainly from technical difficulties and
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limitations that have also been pointed out by some researchers
(Fu et al., 2016). Changes in gut microbe composition are
typically analyzed quantitatively in well-represented bacterial
taxa. The question that is still to be addressed relates to some
small microbial groups. Possibly their quantitatively insignificant
changes may affect host health substantially. Gut microbiota
composition can vary significantly even in well-controlled
cohorts, since other factors (than host genetics) shape the
microbiome (Parks et al., 2013). A representative example is the
diet, which has been demonstrated in a knock-out mice model
as dominating the host genotype in shaping the gut microbiome
(Carmody et al., 2015). As a result, the potential role of the
low-represented microbial groups still remains vague.
A limitation comes from the relatively small size of the
samples, which in microbiome studies have usually been
approximately 1–2 hundred individuals, or less. The sample
sizes necessary to detect significant associations in many GWAS
of common diseases were thousands to tens of thousands of
individuals (Davenport et al., 2015). Additionally, as pointed
out by Davenport et al. (2015), at the current state of research,
published replication cohorts are not available in humans. The
prospects for expanding the volume of available data rely on the
initiative of the Human Microbiome Project1, inspired by the
enhancing need for understanding reciprocal cross-talk between
microbiome and host. One of its major goals is to determine
whether there is an identifiable ‘core microbiome’ of shared
organisms, genes, or functional capabilities found in a given body
habitat of all or the vast majority of humans (Turnbaugh et al.,
2007).
Probably the biggest challenge that remains in the field is to
answer the question: “Is it really the microbiome composition
that causes a health disorder, or do both the health disorder
and the altered microbiome composition result from the same
genomic factor?” Probably both types of relations are possible,
but as yet they have not been clearly discriminated in humans.
It is very likely that a disease causes microbiome changes,
due to effects on several factors that affect microbiota: changes
in intestinal motility, change in appetite and diet, medical
treatment including surgery, changes in lifestyle. All recent
studies of Crohn’s disease confirm that it correlates with
dysbiosis. Particularly, low levels of Firmicutes, Bifidobacteria,
and Lactobacilli have been observed, and higher numbers of
Escherichia coli and other strains of Enterobacteriaceae (Manuc
et al., 2016). However, the use of probiotic bacteria such as
1 http://hmpdacc.org/
Lactobacillus and Bifidobacterium in active Crohn’s disease or
during remissions did not result in clearly conclusive, positive
results. Currently, probiotics are not recommended in Crohn’s
disease (Manuc et al., 2016). This example suggests that, at least
in some cases, the correlation of microbiota composition and
disease phenotype may result from the same detail of the host
genetic profile, and they may not necessarily be directly linked.
On the other hand, there are reports demonstrating transfer
of the gut microbiota between mice as sufficient for the transfer
of a disease phenotype. For instance, a very recent study by
Gacias et al. (2016) revealed that depression-like disorders of
social behavior could be “transferred” between two genetically
distinct strains of mice by the transfer of fecal bacteria. Intestinal
microbes, including members of Clostridiales, Lachnospiraceae,
and Ruminococcaceae, were transferred from the gut of depressed
mice to those exhibiting non-depressed behavior; this was
sufficient to induce social avoidance in the animals. The
mechanism of this effect, as identified by metabolomics analysis,
was related to increased cresol (a metabolite) levels in mice with
the depressive phenotype (Gacias et al., 2016).
We propose that both types of relations between host
genetic profile, gut microbiome composition, and host health
are possible, thus a better understanding may allow for patient-
tailored shaping of microbiome, e.g., by the diet. The field
of microbiome research is anticipated to expand with new
knowledge and clinical potential (Linares et al., 2016). This idea
remains a fascinating area for future inquiry.
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